Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis

Jia Song1, Jia Li1, Xiaochen Pei1

  • 1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.

Plos One
|April 16, 2024
PubMed
Abstract

Insights

This study reveals cuproptosis plays a role in Parkinson's disease (PD) pathogenesis. Key genes PI3 and SERPINI1 were identified as potential therapeutic targets for PD.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Parkinson's disease (PD) is a prevalent neurodegenerative disorder with no effective treatments.
  • Cuproptosis, a form of cell death, is well-studied in cancer but its role in PD is unclear.

Purpose of the Study:

  • To investigate the involvement of cuproptosis in Parkinson's disease.
  • To identify key genes and microRNAs (miRNAs) associated with cuproptosis in PD.

Main Methods:

  • Analysis of gene expression datasets (GSE22491, GSE100054) to identify differentially expressed cuproptosis-related genes (CRGs).
  • Construction of protein-protein interaction (PPI) and weighted gene co-expression network analysis (WGCNA) networks.
  • Identification and validation of key genes (PI3, SERPINI1) and associated miRNAs using qRT-PCR.

Main Results:

  • Identified 525 differentially expressed genes (DEGs) in PD samples.
  • Discovered 2 key genes, peptidase inhibitor 3 (PI3) and neuroserpin family I member 1 (SERPINI1), significantly associated with PD.
  • Found 29 relevant miRNAs, including hsa-miR-30c-2-3p, and confirmed upregulated mRNA expression of PI3 and SERPINI1 in PD.

Conclusions:

  • Cuproptosis is implicated in the pathogenesis of Parkinson's disease.
  • Identified key genes and miRNAs provide novel insights for molecular targeting treatments for PD.